Ref.: BL-RE-091029Manufacturer ref.: EH314RBX5 5 x 96 tests
€2,950.00 excl. VAT
Human Matrilin-3 quantitates human Matrilin-3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Matrilin-3.
Human Matrilin-3 quantitates human Matrilin-3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Matrilin-3.
Human Matrilin-3 quantitates human Matrilin-3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Matrilin-3.
Matrilines (MATN) are a non-collagen extracellular matrix protein (ECM) family composed of four known members that were proposed to play key roles in cell phenotype modulation during mesenchymal stem cell chondrogenesis (MSC). MATN1 and MATN3 are specifically expressed in cartilage and are among the most regulated MEC proteins during chondrogenesis. MATN3 is composed of a domain of von Willebrand's factor A (vWFA) of single N-terminal end followed by four epidermal growth factor (EGF) repeats and a super-propeller domain while MATN1 consists of two vWFA domains separated by a domain similar to the EGF. MATN1 or MATN3 may play a role in the modulation of chondrogenesis during the chondrocyte differentiation process. Mutations of this gene have been associated with various hereditary chondrodysplasias. Recent studies show that outliers and treatment of MATN3 are characteristic of conventional cartilaginous neoplasms.
Sensitivity
Sensitivity of the dosage: 20 pg/ml.
Measurement range
Dose range: 20 to 5,000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Matriline 3.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).